Publications 2017

Dănilă, M.D., Privistirescu, A., Duicu, O.M., Rațiu, C.D., Angoulvant, D., Muntean, D.M., Sturza, A., 2017. The effect of purinergic signaling via the P2Y11 receptor on vascular function in a rat model of acute inflammation. Mol. Cell. Biochem. 431, 37–44.
Dumas, J.-F., Brisson, L., Chevalier, S., Mahéo, K., Fromont, G., Moussata, D., Besson, P., Roger, S., 2017. Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to anticancer treatment. Semin. Cancer Biol. 43, 90–110.
Forconi, C., Gatault, P., Miquelestorena-Standley, E., Noble, J., Al-Hajj, S., Guillemain, R., Stern, M., Hoffmann, T., Prat, L., Suberbielle, C., Masson, E., Cesbron-Gautier, A., Gaudy-Graffin, C., Goudeau, A., Thibault, G., Ivanes, F., Guibon, R., Kazma, I., Lebranchu, Y., Büchler, M., Magnan, A., Halimi, J.-M., Baron, C., 2017. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors. J. Heart Lung Transplant. 36, 315–324.
Harguindey, S., Stanciu, D., Devesa, J., Alfarouk, K., Cardone, R.A., Polo Orozco, J.D., Devesa, P., Rauch, C., Orive, G., Anitua, E., Roger, S., Reshkin, S.J., 2017. Cellular acidification as a new approach to cancer treatment and to the understanding and therapeutics of neurodegenerative diseases. Semin. Cancer Biol. 43, 157–179.
Jiang, L.-H., Mousawi, F., Yang, X., Roger, S., 2017. ATP-induced Ca2+-signalling mechanisms in the regulation of mesenchymal stem cell migration. Cell. Mol. Life Sci. 74, 3697–3710.
Khalid, M., Brisson, L., Tariq, M., Hao, Y., Guibon, R., Fromont, G., Mortadza, S.A.S., Mousawi, F., Manzoor, S., Roger, S., Jiang, L.-H., 2017. Carcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells. Oncotarget 8, 37278–37290.
Moussata, D., Allez, M., Cazals-Hatem, D., Treton, X., Laharie, D., Reimund, J.-M., Bertheau, P., Bourreille, A., Lavergne-Slove, A., Brixi, H., Branche, J., Gornet, J.-M., Stefanescu, C., Moreau, J., Marteau, P., Pelletier, A.-L., Carbonnel, F., Seksik, P., Simon, M., Fléjou, J.-F., Colombel, J.-F., Charlois, A.-L., Roblin, X., Nancey, S., Bouhnik, Y., Berger, F., Flourié, B., the GETAID, 2018. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut 67, 616–624.
Paintaud, G., Passot, C., Ternant, D., Bertolotto, A., Bejan-Angoulvant, T., Pascual-Salcedo, D., Mulleman, D., 2017. Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases. Ther Drug Monit 39, 339–343.
Terciolo, C., Dobric, A., Ouaissi, M., Siret, C., Breuzard, G., Silvy, F., Marchiori, B., Germain, S., Bonier, R., Hama, A., Owens, R., Lombardo, D., Rigot, V., André, F., 2017. Saccharomyces boulardii CNCM I-745 Restores intestinal Barrier Integrity by Regulation of E-cadherin Recycling. J Crohns Colitis 11, 999–1010.
Ternant, D., Ivanes, F., Prunier, F., Mewton, N., Bejan-Angoulvant, T., Paintaud, G., Ovize, M., Angoulvant, D., 2017. Revisiting myocardial necrosis biomarkers: assessment of the effect of conditioning therapies on infarct size by kinetic modelling. Sci Rep 7, 10709.